Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul G Corn

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
BMC Biochemistry|December 6, 2007
Role of the ubiquitin proteasome system in renal cell carcinomaPaul G Corn
Cancer Management and Research|August 21, 2012
The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy developmentPaul G Corn
Current Oncology Reports|April 10, 2013
Optimal therapy sequencing in metastatic castration-resistant prostate cancerSausan Abouharb, Paul G Corn
Cancer Management and Research|December 29, 2010
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefitPaul G Corn, Timothy C Thompson
Cancer Biology & Therapy|October 19, 2010
MDM-2 antagonists induce p53-dependent cell cycle arrest but not cell death in renal cancer cell linesChun Chui Tsao, Paul G Corn
Cell Cycle (Georgetown, Tex.)|July 8, 2008
Hypoxic regulation of mRNA expressionLawrence B Gardner, Paul G Corn
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 10, 2002
Derangement of growth and differentiation control in oncogenesisPaul G Corn, Wafik S El-Deiry
Cancer Biology & Therapy|December 19, 2007
Microarray analysis of p53-dependent gene expression in response to hypoxia and DNA damagePaul G Corn, Wafik S El-Deiry
Cancer Biology & Therapy|December 23, 2003
Caspase 10 levels are increased following DNA damage in a p53-dependent mannerBart Rikhof, Paul G Corn, Wafik S El-Deiry
Current Opinion in Oncology|April 1, 2026
Optimal management of oligometastatic prostate cancer: current state and future directionsMichael K Rooney, Paul G Corn, Phuoc T Tran
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
BMC Biochemistry|December 6, 2007
Role of the ubiquitin proteasome system in renal cell carcinomaPaul G Corn
Cancer Management and Research|August 21, 2012
The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy developmentPaul G Corn
Current Oncology Reports|April 10, 2013
Optimal therapy sequencing in metastatic castration-resistant prostate cancerSausan Abouharb, Paul G Corn
Cancer Management and Research|December 29, 2010
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefitPaul G Corn, Timothy C Thompson
Cancer Biology & Therapy|October 19, 2010
MDM-2 antagonists induce p53-dependent cell cycle arrest but not cell death in renal cancer cell linesChun Chui Tsao, Paul G Corn
Cell Cycle (Georgetown, Tex.)|July 8, 2008
Hypoxic regulation of mRNA expressionLawrence B Gardner, Paul G Corn
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 10, 2002
Derangement of growth and differentiation control in oncogenesisPaul G Corn, Wafik S El-Deiry
Cancer Biology & Therapy|December 19, 2007
Microarray analysis of p53-dependent gene expression in response to hypoxia and DNA damagePaul G Corn, Wafik S El-Deiry
Cancer Biology & Therapy|December 23, 2003
Caspase 10 levels are increased following DNA damage in a p53-dependent mannerBart Rikhof, Paul G Corn, Wafik S El-Deiry
Current Opinion in Oncology|April 1, 2026
Optimal management of oligometastatic prostate cancer: current state and future directionsMichael K Rooney, Paul G Corn, Phuoc T Tran
Pageof 10